Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


POYHONEN JOHN Create: Alert

All | News | Filings
Date FiledTypeDescription
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2023 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 66,385 rights @ $0
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2022 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 2,012 shares @ $3.76, valued at $7.6k
Exercised 1,250 restricted stock units @ $0
Exercised 4,564 restricted stock units @ $0
07/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2022 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 2,012 shares @ $6.07, valued at $12.2k
Exercised 1,250 restricted stock units @ $0
Exercised 4,564 restricted stock units @ $0
01/14/2022 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 2,012 shares @ $8.3, valued at $16.7k
Exercised 1,250 restricted stock units @ $0
Exercised 4,564 restricted stock units @ $0
12/23/2021 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 817 shares @ $9.3585, valued at $7.6k
10/15/2021 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 433 shares @ $10.55, valued at $4.6k
Exercised 1,250 restricted stock units @ $0
Granted 92,200 options to buy @ $10.55, valued at $972.7k
Granted 55,320 restricted stock units @ $0
07/15/2021 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 971 shares @ $13.8975, valued at $13.5k
Paid exercise price by delivering 433 shares @ $13.48, valued at $5.8k
Exercised 1,250 restricted stock units @ $0
04/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2020 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 637 shares @ $11.6535, valued at $7.4k
10/15/2020 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 170,000 options to buy @ $15.72, valued at $2.7M
Granted 20,000 restricted stock units @ $0
12/23/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2019 4 POYHONEN JOHN (EVP, Chief Commercial Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 300,000 options to buy @ $18.29, valued at $5.5M
05/23/2019 4 POYHONEN JOHN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Bought 3,000 shares @ $17.55, valued at $52.7k
12/18/2018 4 POYHONEN JOHN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 19,500 options to buy @ $24.97, valued at $486.9k
Granted 30,000 options to buy @ $24.97, valued at $749.1k
11/02/2018 4 POYHONEN JOHN (President & CEO) has filed a Form 4 on SENOMYX INC
Txns: Unknown transaction of 111,469 shares @ $1.5, valued at $167.2k
Unknown transaction of 108,293 shares @ $1.5, valued at $162.4k
Disposed/sold 417,000 options to buy @ $1.02, valued at $425.3k
Disposed/sold 363,000 options to buy @ $1.05, valued at $381.2k
03/21/2018 4 POYHONEN JOHN (President & CEO) has filed a Form 4 on SENOMYX INC
Txns: Granted 15,545 shares @ $0
Granted 363,000 options to buy @ $1.05, valued at $381.2k
12/20/2017 4 POYHONEN JOHN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 19,500 options to buy @ $17, valued at $331.5k
03/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/23/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/17/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/02/2016 4 POYHONEN JOHN (President & CEO) has filed a Form 4 on SENOMYX INC
Txns: Granted 2,191 shares @ $2.8988, valued at $6.4k
04/17/2013 4 POYHONEN JOHN (See Remarks) has filed a Form 4 on SENOMYX INC
Txns: Granted 4,438 shares @ $0
Granted 205,000 options to buy @ $2.11, valued at $432.6k
06/20/2012 4 POYHONEN JOHN (Director) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns: Disposed/sold 12,500 options to buy @ $5.85, valued at $73.1k
Disposed/sold 12,500 options to buy @ $15.69, valued at $196.1k
Disposed/sold 10,000 options to buy @ $15.69, valued at $156.9k
Disposed/sold 12,500 options to buy @ $12.16, valued at $152k
Disposed/sold 5,000 options to buy @ $12.16, valued at $60.8k
Disposed/sold 12,500 options to buy @ $14.29, valued at $178.6k
Disposed/sold 12,500 options to buy @ $25.97, valued at $324.6k
Disposed/sold 12,500 options to buy @ $16.47, valued at $205.9k
03/01/2012 4 POYHONEN JOHN (See Remarks) has filed a Form 4 on SENOMYX INC
Txns: Granted 1,880 shares @ $0
02/16/2012 4 POYHONEN JOHN (See Remarks) has filed a Form 4 on SENOMYX INC
Txns: Granted 225,000 options to buy @ $3.3, valued at $742.5k
01/05/2012 4 POYHONEN JOHN (Director) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns: Granted 12,500 options to buy @ $16.47, valued at $205.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy